French endocrine diseases specialist Amolyt Pharma SA has entered into a take-over agreement by AstraZeneca.
Up To Date
Latest News
London-based virtual drug discovery specialist Relation Therapeutics Ltd has closed another US$35m seed...
TREM2, a receptor on the surface of macrophages, reduces necrotic core formation in early atherosclerosis, a...
British companies Arecor Therapeutics plc and TRx Biosciences Ltd combine their technologies to formulate an...
German researchers for the first time have expanded the half life of oligonucleotide-based drugs using...
Rare disease specialist SynaptixBio Ltd has got its second FDA orphan drug designation for a subtype of TUBB4A...